Condition: Glenohumeral Osteoarthritis · Proximal Humerus Fracture · Rotator Cuff Arthropathy · Sponsor: TIPMED Medical Device Manufacturing Ltd. Co.
This study is designed as a prospective, multicenter, observational post-market clinical follow-up (PMCF) study to evaluate the safety and effectiveness of the Tipmed™ Shoulder Prosthesis System at 12 months postoperatively. The study population includes adult patients who undergo reverse shoulder arthroplasty (RSA) or shoulder hemiarthroplasty (HA) using the Tipmed™ implant systems due to various clinical indications such as osteoarthritis, rotator cuff arthropathy, or proximal humerus fractures. The main objective is to gather real-world clinical evidence on the 12-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.
This description comes directly from the study's public registry record.
Yasemin Önel, Sponsor Rep · +90 232 479 33 22 · yaseminonel@tipmed.com
Always discuss trial participation with your own doctor first.
| Republic of Turkey Ministry of Health, Balıkesir Provincial Health Directorate, Atatürk City Hospital | Balıkesir, Turkey (Türkiye) | Recruiting |
| Republic of Turkey Ministry of Health, Istanbul Provincial Health Directorate, Kanuni Sultan Suleyman Training and Research Hospital | Istanbul, Turkey (Türkiye) | Not Yet Recruiting |
| Republic of Turkey Ministry of Health, Izmir Provincial Health Directorate, Bakircay University Cigli Training and Research Hospital | Izmir, Turkey (Türkiye) | Not Yet Recruiting |
| Dokuz Eylül University Research and Application Hospital | Izmir, Turkey (Türkiye) | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07678034